NGeneBio exhibited at HIMSS 2023, the world's largest healthcare IT exhibition, which took place in Chicago, USA from April 17 to April 21, 2023.

At this exhibition, NGeneBio introduced innovative precision diagnostic platform technologies and solutions, including their disease genomics automated analysis software, NGeneAnalySys. Through this, NGeneBio showcased advanced analysis technologies for precise cancer diagnosis and digital healthcare solutions, aiming to expand business partnerships and marketing activities for their entry into the U.S. market.

Participation in this event provided NGeneBio with a valuable opportunity to actively promote their cancer genomics analysis and digital healthcare solutions, laying the foundation for their forthcoming entry into the U.S. healthcare market later this year.

For more detailed information about HIMSS 2023, please visit www.himss.org